Mobia Medical, Inc. director Myriam Curet received two stock option awards on 2026-07-30: one for 19,740 options and another for 15,960 options, each exercisable for common stock at an exercise price of $11.1800 per share. The first option vests in three substantially equal annual installments on the first three anniversaries of the grant date; the second fully vests at the 2027 Annual Meeting under the Non-Employee Director Compensation Policy. Both options expire on 2036-07-30.
Mobia Medical, Inc. director Myriam Curet has filed an initial insider ownership report for the company. The disclosure identifies her role as a director, reports no equity transactions or derivative positions, and notes an attached Exhibit 24 Power of Attorney authorizing the filing on her behalf.
Mobia Medical, Inc. expanded its Board of Directors from seven to eight members effective July 30, 2026 and appointed Myriam J. Curet, M.D. as a new Class II director. Her term runs until the company’s 2028 annual meeting of stockholders, or until a successor is elected and qualified.
The Board determined that Dr. Curet qualifies as an independent director under SEC and Nasdaq rules. She is not yet assigned to any Board committee and will receive compensation under Mobia’s non-employee director compensation program, along with the company’s standard indemnification agreement. The company states there are no related-party transactions with Dr. Curet requiring disclosure.
Mobia Medical, Inc. director Reza Zadno received two stock option awards covering 16,260 and 19,150 shares of common stock at an exercise price of $11.57 per share, expiring on July 14, 2036. Vesting schedules include three substantially equal annual installments and full vesting at the 2027 Annual Meeting.
Mobia Medical, Inc. director Reza Zadno has filed an initial statement of beneficial ownership of securities on Form 3 as a reporting person. The available structured data lists no buy or sell transactions, derivative exercises, gifts, tax withholdings, or other derivative holdings associated with this filing.
Mobia Medical, Inc. expanded its Board of Directors from six to seven members and appointed Reza Zadno, Ph.D. as a new Class III director. His term extends until Mobia’s 2029 annual meeting of stockholders, or until a successor is elected and qualified or he departs earlier.
Dr. Zadno was also appointed to the Board’s Compensation Committee, which now comprises Casey Tansey (chair), Dana Mead and Dr. Zadno, following Dr. William Harrington’s resignation from the committee. The Board determined that Dr. Zadno qualifies as an independent director under SEC and Nasdaq rules. He brings prior CEO experience at PROCEPT BioRobotics Corporation and Avedro, Inc., as well as multiple medical device and biopharma board roles. He will be compensated under Mobia’s non-employee director compensation program, and Mobia expects to enter into its standard indemnification agreement with him.
Mobia Medical, Inc. insiders affiliated with Green Park & Golf Ventures entities reported multiple conversions of preferred stock and convertible notes into Common Stock on May 11, 2026. These were coded as derivative conversions rather than open‑market trades, so no shares were bought or sold for cash.
The filing shows various series of preferred stock and Convertible Notes automatically converted into Common Stock immediately before Mobia Medical’s initial public offering, pursuant to their terms. After these conversions, the reporting LLCs hold only Common Stock positions, all reported as indirect ownership.
Green Park & Golf Ventures II, LLC is the managing member of several holding LLCs, and its managers Clay M. Heighten, MD, Carl D. Soderstrom and Gilbert G. Garcia II share voting and dispositive power and may be deemed to beneficially own the converted shares.
Mobia Medical, Inc. disclosed that investment entities associated with Green Park & Golf Ventures Houston increased their indirect stake through a mix of preferred stock conversions and an open-market purchase. On May 11, 2026, these entities bought 60,537 shares of common stock at $15.00 per share in an open-market transaction.
In addition, shares of Series F, Series E-1 and Series E-2 Preferred Stock held by HTX MCT1–MCT4 investment LLCs were converted into common stock immediately prior to Mobia Medical’s initial public offering pursuant to their terms, including conversions into 126,005, 138,233, 83,579 and 38,875 common shares. Green Park & Golf Ventures Houston is the managing member of the HTX entities, and managers Clay M. Heighten, Carl D. Soderstrom and Gilbert G. Garcia II share voting and dispositive power over the converted shares.
Mobia Medical, Inc. reported that investment entities affiliated with Green Park & Golf Ventures II, LLC and related holders converted multiple preferred stock series, warrants and convertible notes into Common Stock, largely eliminating these derivatives immediately prior to the company’s initial public offering.
The filing shows conversions of Series B, Series D, Series F, Series E-1 and Series E-2 Preferred Stock into Common Stock, as well as Convertible Notes that converted into Common Stock under a formula based on the Offering price and pre‑offering valuation. A warrant to purchase Series B Preferred Stock was exercised, issuing Common Stock at an exercise price of $3.73744 per share with the warrant otherwise expiring on December 14, 2032.
In addition to these non‑cash conversions, an affiliated entity reported an open‑market purchase of 33,333 shares of Common Stock at $15.00 per share, increasing indirect holdings. All reported positions are held indirectly through LLCs managed by GPG Ventures II and its managers, who share voting and dispositive power over the securities.
Mobia Medical, Inc. reported a large restructuring of holdings by Green Park & Golf Ventures–affiliated investment entities around its initial public offering. Multiple series of preferred stock, warrants and convertible notes held by LLCs such as JCT, MTI 22, MTI 25, MTI 3-17, PHL and RM converted into Common Stock immediately before the offering, turning prior derivative positions into equity stakes.
As part of a cashless warrant exercise by RM, 6,731 shares of Common Stock were withheld to pay the exercise price and 159 shares were issued, so this disposition reflects tax/exercise mechanics rather than an open-market sale. Green Park & Golf Ventures II, LLC manages the LLC holders, and its managers Clay M. Heighten, Carl D. Soderstrom and Gilbert G. Garcia II may be deemed to share beneficial ownership of the resulting Common Stock positions.